Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Revealing the BRD4-NOTCH3 fusion: A novel hill in the cancer landscape.

Lung cancer (Amsterdam, Netherlands) - 1 Apr 2021

Costa Fabiano de Almeida, Amano Mariane Tami, Asprino Paula Fontes, Pavlick Dean C, Masotti Cibele, Testagrossa Leonardo, de Castro Gilberto

Abstract excerpt

OBJECTIVES: Gene fusions are becoming more evident in cancer scenario for either being the driver alterations, or for the great therapeutic target potential in many cases. Our aim was to characterize the BRD4-NOTCH3 fusion correlating with clinical features, and to determine the frequency of this fusion in the oncological population. MATERIAL AND METHODS: One patient diagnosed with lung adenocarcinoma at Hospital...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma of Lung
Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Brazil

Share to Cell Cycle Proteins

Share to Lung Neoplasms

Share to Nuclear Proteins

Share to Receptor, Notch3

Share to Transcription Factors

Source

Identifiers

PMID: 33676359
DOI: 10.1016/j.lungcan.2021.02.016

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Revealing the BRD4-NOTCH3 fusion: A novel hill in the cancer landscape.PMID 33676359Read ↗

Clinically relevant fusion oncogenes: detection and practical implicationsSemantic proximity Read ↗

Characterizing the molecular and clinical implications of NRG1 fusions in NSCLC through integrated RNA and DNA sequencing analysis.Semantic proximity Read ↗

Oncogenic Fusions in NSCLC: From Mechanisms to Clinical ApplicationsSemantic proximity Read ↗

NRG1 Gene Fusions—What Promise Remains Behind These Rare Genetic Alterations? A Comprehensive Review of Biology, Diagnostic Approaches, and Clinical ImplicationsSemantic proximity Read ↗

Detection of NRG1 Gene Fusions in Solid TumorsSemantic proximity Read ↗

Expert Consensus on the Diagnosis and Treatment of NRG1/2 Gene Fusion Solid TumorsSemantic proximity Read ↗

Unveiling the Uncommon: Targeting Rare MET Fusions in NSCLC: A Comprehensive ReviewSemantic proximity Read ↗

Landscape of potentially targetable receptor tyrosine kinase fusions in diverse cancers by DNA-based profilingSemantic proximity Read ↗

Identification of MET fusions as novel therapeutic targets sensitive to MET inhibitors in lung cancer.Semantic proximity Read ↗

Identification of a novel GOPC-RET fusion in a patient with lung adenocarcinoma: A case reportSemantic proximity Read ↗

Landscape analysis of adjacent gene rearrangements reveals BCL2L14-ETV6 gene fusions in more aggressive triple-negative breast cancer.Semantic proximity Read ↗

Effective Treatment With Endostar and Crizotinib Sequential Alectinib in a Lung Adenocarcinoma Patient With Brain Metastases Harboring a Novel CLHC1/RNT4 Intergenic Region- ALK FusionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.